Read more: To view or add a comment, sign in A diabetes drug changed the trajectory of kidney disease
For example, while EVs from GDM patients can induce glucose intolerance in pregnant mice, 52 significant differences in placental structure and metabolic regulation between mice and humans limit the clinical translation of such findings
Efficacy and safety Beyond its primary use for type 2 diabetes, tirzepatide has been explored for its potential in treating obesity, osteoarthritis of the knee, atherosclerosis, and other metabolic diseases
Using the same spot repeatedly can cause lipodystrophy, localized changes in fat tissue that affect both aesthetics and absorption consistency
You can support this coordination by signing release forms that allow your providers to communicate directly and by bringing your eye exam reports to your diabetes appointments
**Doses of 68 mg require reconstituting 2 vials (each with 1.0 mL)